Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rockwell Medical (RMTI) Return on Sales (2016 - 2025)

Rockwell Medical's Return on Sales history spans 16 years, with the latest figure at 0.03% for Q4 2025.

  • For Q4 2025, Return on Sales changed 0.0% year-over-year to 0.03%; the TTM value through Dec 2025 reached 0.08%, down 8.0%, while the annual FY2025 figure was 0.08%, 8.0% down from the prior year.
  • Return on Sales reached 0.03% in Q4 2025 per RMTI's latest filing, up from 0.11% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.06% in Q3 2024 to a low of 0.58% in Q4 2021.
  • Average Return on Sales over 5 years is 0.2%, with a median of 0.11% recorded in 2025.
  • Peak YoY movement for Return on Sales: dropped -17bps in 2021, then surged 46bps in 2022.
  • A 5-year view of Return on Sales shows it stood at 0.58% in 2021, then skyrocketed by 79bps to 0.12% in 2022, then skyrocketed by 40bps to 0.07% in 2023, then surged by 57bps to 0.03% in 2024, then fell by -10bps to 0.03% in 2025.
  • Per Business Quant, the three most recent readings for RMTI's Return on Sales are 0.03% (Q4 2025), 0.11% (Q3 2025), and 0.1% (Q2 2025).